Xenon Pharmaceuticals
XENE
XENE
150 hedge funds and large institutions have $1.62B invested in Xenon Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 56 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
1.22% less ownership
Funds ownership: 94.71% → 93.49% (-1.2%)
74% less call options, than puts
Call options by funds: $1.03M | Put options by funds: $4.05M
Holders
150
Holding in Top 10
8
Calls
$1.03M
Puts
$4.05M
Top Buyers
| 1 | +$49.9M | |
| 2 | +$33.2M | |
| 3 | +$28M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$22.5M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$21.7M |
Top Sellers
| 1 | -$37.9M | |
| 2 | -$21.2M | |
| 3 | -$13.4M | |
| 4 |
Goldman Sachs
New York
|
-$13M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$9.38M |